Bionovate Technologies Corp
BIIO
$0.0001
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 107.33% | 37.58% | 4.69% | -30.74% | -57.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.33% | 37.58% | 4.69% | -30.74% | -57.66% |
| Operating Income | -107.33% | -37.58% | -4.69% | 30.74% | 57.66% |
| Income Before Tax | 8.91% | 12.69% | 25.58% | 31.28% | 23.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.91% | 12.69% | 25.58% | 31.28% | 23.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.91% | 12.69% | 25.58% | 31.28% | 23.29% |
| EBIT | -107.33% | -37.58% | -4.69% | 30.74% | 57.66% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 98.23% | 99.42% | 99.74% | 99.79% | 69.63% |
| Normalized Basic EPS | 98.26% | 99.44% | 99.76% | 99.80% | 69.64% |
| EPS Diluted | 98.23% | 99.42% | 99.74% | 99.79% | 69.63% |
| Normalized Diluted EPS | 98.26% | 99.44% | 99.76% | 99.80% | 69.64% |
| Average Basic Shares Outstanding | -19.44% | 79.70% | 440.02% | 34,601.25% | 25,500.79% |
| Average Diluted Shares Outstanding | -19.44% | 79.70% | 440.02% | 34,601.25% | 25,500.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |